Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (45) 45
female (38) 38
adult (35) 35
index medicus (34) 34
middle aged (34) 34
oncology (34) 34
aged (31) 31
medicine & public health (27) 27
male (26) 26
surgery (26) 26
prognosis (23) 23
aged, 80 and over (22) 22
sarcoma (21) 21
management (19) 19
retrospective studies (18) 18
traumatic surgery (18) 18
cancer (17) 17
chemotherapy (16) 16
survival (14) 14
follow-up studies (12) 12
prognostic-factors (12) 12
neoplasm staging (11) 11
analysis (10) 10
metastasis (10) 10
radiology, nuclear medicine & medical imaging (10) 10
sports medicine (10) 10
tumors (10) 10
adolescent (9) 9
radiotherapy (9) 9
sarcoma - surgery (9) 9
diagnosis (8) 8
disease-free survival (8) 8
ovarian neoplasms - pathology (8) 8
sarcoma - pathology (8) 8
soft tissue neoplasms - pathology (8) 8
soft tissue sarcoma (8) 8
soft-tissue sarcoma (8) 8
survival rate (8) 8
treatment outcome (8) 8
extremity (7) 7
medicine/public health, general (7) 7
multivariate analysis (7) 7
neoplasm recurrence, local (7) 7
ovarian cancer (7) 7
pathology (7) 7
radiation-therapy (7) 7
recurrence (7) 7
surgical oncology (7) 7
survival analysis (7) 7
young adult (7) 7
antineoplastic agents - therapeutic use (6) 6
carcinoma (6) 6
care and treatment (6) 6
classification (6) 6
combined modality therapy (6) 6
impact (6) 6
neoadjuvant chemotherapy (6) 6
orthopedics (6) 6
resection (6) 6
sarcoma - mortality (6) 6
comparative genomic hybridization (5) 5
complications (5) 5
cytoreductive surgery (5) 5
hematology, oncology and palliative medicine (5) 5
leiomyosarcoma (5) 5
neoadjuvant therapy (5) 5
neoplasm recurrence, local - pathology (5) 5
ovarian neoplasms - surgery (5) 5
patients (5) 5
research article (5) 5
retroperitoneal neoplasms - pathology (5) 5
retroperitoneal sarcoma (5) 5
risk factors (5) 5
sarcoma - radiotherapy (5) 5
tumor grade (5) 5
development and progression (4) 4
endometrial neoplasms - surgery (4) 4
expression (4) 4
follow-up (4) 4
leiomyosarcoma - pathology (4) 4
liposarcoma (4) 4
medical prognosis (4) 4
medicine (4) 4
neoplasm invasiveness (4) 4
obstetrics & gynecology (4) 4
patient outcomes (4) 4
prognostic factors (4) 4
radiotherapy dosage (4) 4
radiotherapy, adjuvant (4) 4
research (4) 4
retroperitoneal neoplasms - surgery (4) 4
sarcoma - drug therapy (4) 4
sarcoma - therapy (4) 4
soft tissue neoplasms - mortality (4) 4
soft tissue neoplasms - surgery (4) 4
soft tissue neoplasms - therapy (4) 4
surgical orthopedics (4) 4
therapy (4) 4
trials (4) 4
uterine neoplasms - pathology (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Primary Retroperitoneal Sarcomas: A Multivariate Analysis of Surgical Factors Associated With Local Control
by Sylvie Bonvalot and Michel Rivoire and Marine Castaing and Eberhard Stoeckle and Axel Le Cesne and Jean Yves Blay and Agnès Laplanche
Journal of Clinical Oncology, ISSN 0732-183X, 01/2009, Volume 27, Issue 1, pp. 31 - 37
Purpose To define the optimal initial management and the best extent of surgery that would optimize margins on primary retroperitoneal sarcomas (RPS). Patients... 
SURVIVAL | OPERATIVE MANAGEMENT | RE-EXCISION | PROGNOSTIC-FACTORS | ONCOLOGY | RESECTION | FOLLOW-UP | CLASSIFICATION | OUTCOMES | SOFT-TISSUE SARCOMA | RADIATION-THERAPY | Multivariate Analysis | Prognosis | Soft Tissue Neoplasms - mortality | Humans | Middle Aged | Neoplasm Recurrence, Local | Male | Retroperitoneal Neoplasms - mortality | Soft Tissue Neoplasms - surgery | Adolescent | Soft Tissue Neoplasms - pathology | Aged, 80 and over | Adult | Female | Aged | Retroperitoneal Neoplasms - pathology | Retroperitoneal Neoplasms - surgery
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Prognostic Factors Influencing Progression-Free Survival Determined From a Series of Sporadic Desmoid Tumors: A Wait-and-See Policy According to Tumor Presentation
by Sébastien Salas and Armelle Dufresne and Binh Bui and Jean-Yves Blay and Philippe Terrier and Dominique Ranchere-Vince and Sylvie Bonvalot and Eberhard Stoeckle and Louis Guillou and Axel Le Cesne and Odile Oberlin and Véronique Brouste and Jean-Michel Coindre
Journal of Clinical Oncology, ISSN 0732-183X, 09/2011, Volume 29, Issue 26, pp. 3553 - 3558
Purpose Desmoid tumors are mesenchymal fibroblastic/myofibroblastic proliferations with locoregional aggressiveness and high ability to recur after initial... 
SURGERY | FOLLOW-UP | AGGRESSIVE FIBROMATOSIS | MANAGEMENT | ONCOLOGY | RADIATION-THERAPY | Fibromatosis, Aggressive - diagnosis | Multivariate Analysis | Prognosis | Europe | Humans | Middle Aged | Child, Preschool | Infant | Male | Fibromatosis, Aggressive - therapy | Adolescent | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Child
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Technical Considerations in Surgery for Retroperitoneal Sarcomas: Position Paper from E-Surge, a Master Class in Sarcoma Surgery, and EORTC–STBSG
by Bonvalot, Syvie and Raut, Chandrajit P and Pollock, Raphael E and Rutkowski, Piotr and Strauss, Dirk C and Hayes, Andrew J and Van Coevorden, Frits and Fiore, Marco and Stoeckle, Eberhard and Hohenberger, Peter and Gronchi, Alessandro
Annals of Surgical Oncology, ISSN 1068-9265, 9/2012, Volume 19, Issue 9, pp. 2981 - 2991
Surgery is the principal treatment for retroperitoneal sarcoma. These tumors typically involve or abut multiple organs and therefore require multivisceral... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURVIVAL | SURGERY | SINGLE INSTITUTION | MANAGEMENT | MORBIDITY | ONCOLOGY | RESECTION | GRADE | EXPERIENCE | RECURRENCE | SOFT-TISSUE SARCOMA | Sarcoma - diagnosis | Retroperitoneal Neoplasms - surgery | Sarcoma - surgery | Humans | Retroperitoneal Neoplasms - diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text MED12 alterations in both human benign and malignant uterine soft tissue tumors
by Pérot, Gaëlle and Croce, Sabrina and Ribeiro, Agnès and Lagarde, Pauline and Velasco, Valérie and Neuville, Agnès and Coindre, Jean-Michel and Stoeckle, Eberhard and Floquet, Anne and MacGrogan, Gaëtan and Chibon, Frédéric
PLoS ONE, ISSN 1932-6203, 06/2012, Volume 7, Issue 6, p. e40015
The relationship between benign uterine leiomyomas and their malignant counterparts, i.e. leiomyosarcomas and smooth muscle tumors of uncertain malignant... 
NEOPLASMS | LEIOMYOSARCOMA | LEIOMYOMA | MEDIATOR | MULTIDISCIPLINARY SCIENCES | X-CHROMOSOME INACTIVATION | BROAD LIGAMENT | COMPARATIVE GENOMIC HYBRIDIZATION | ABERRATIONS | BETA-CATENIN EXPRESSION | CLONAL ORIGINS | Mediator Complex - metabolism | Uterine Neoplasms - pathology | Humans | DNA, Complementary - genetics | Gene Expression Regulation, Neoplastic | Molecular Sequence Data | Leiomyoma - pathology | Smooth Muscle Tumor - genetics | Cell Transformation, Neoplastic - genetics | DNA Mutational Analysis | Base Sequence | Female | Soft Tissue Neoplasms - genetics | Uterine Neoplasms - genetics | Mediator Complex - genetics | Smooth Muscle Tumor - pathology | Mutation - genetics | beta Catenin - metabolism | Genome, Human - genetics | Protein Transport | Wnt Signaling Pathway - genetics | Alleles | Soft Tissue Neoplasms - pathology | Cell Transformation, Neoplastic - pathology | Leiomyoma - genetics | Immunohistochemistry | Development and progression | Gene mutations | Cancer | Wnt protein | Mesenchyme | Smooth muscle | Subgroups | β-catenin | Alterations | Uterus | Genetics | Tumorigenesis | Localization | Deoxyribonucleic acid--DNA | Sequences | Hot spots | Benign | Muscles | Fibroids | Breast cancer | RNA polymerase | Gene expression | Pathology | MicroRNAs | Pancreatic cancer | Mutation | Tumors | Deoxyribonucleic acid | DNA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Quality of surgery and surgical reporting for patients with primary gastrointestinal stromal tumours participating in the EORTC STBSG 62024 adjuvant imatinib study
by Hohenberger, Peter and Bonvalot, Sylvie and van Coevorden, Frits and Rutkowski, Pjotr and Stoeckle, Eberhard and Olungu, Christine and Litiere, Saskia and Wardelmann, Eva and Gronchi, Alessandro and Casali, Paolo
European Journal of Cancer, ISSN 0959-8049, 10/2019, Volume 120, pp. 47 - 53
EORTC (European Organisation of Research and Treatment of Cancer) 62024 is a phase III randomised trial evaluating adjuvant imatinib in patients with... 
Imatinib | Surgical reporting | Surgical treatment | Adjuvant treatment | Gastro-intestinal stromal tumor | Quality assessment | Surgical oncology trials | TRIALS | DIAGNOSIS | GIST | RESECTION | CANCER | ONCOLOGY | GRADE | RECURRENCE | Endoscopes | Surgery | Rupture | Questionnaires | Surgeons | Laparoscopy | Endoscopy | Patients | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text First-in-human study testing a new radioenhancer using nanoparticles (NBTXR3) activated by radiation therapy in patients with locally advanced soft tissue sarcomas
by Bonvalot, Sylvie and Le Pechoux, Cécile and De Baere, Thierry and Kantor, Guy and Buy, Xavier and Stoeckle, Eberhard and Terrier, Philippe and Sargos, Paul and Coindre, Jean Michel and Lassau, Nathalie and Sarkouh, Rafik Ait and Dimitriu, Mikaela and Borghi, Elsa and Levy, Laurent and Deutsch, Eric and Soria, Jean-Charles
Clinical Cancer Research, ISSN 1078-0432, 02/2017, Volume 23, Issue 4, pp. 908 - 917
Purpose: This phase I study aimed to determine the recommended dose (RD), safety profile, and feasibility of a procedure combining intratumoral injection of... 
INDUCED PATHOLOGICAL NECROSIS | MANAGEMENT | HIGH-GRADE | ONCOLOGY | PREOPERATIVE RADIOTHERAPY | NEOADJUVANT RADIOTHERAPY | POSTOPERATIVE RADIOTHERAPY | EXTREMITY | RANDOMIZED-TRIAL | HAFNIUM OXIDE NANOPARTICLES | CHEMOTHERAPY | Neoplasm, Residual - pathology | Neoplasm Recurrence, Local - radiotherapy | Nanoparticles - chemistry | Humans | Middle Aged | Oxides - chemistry | Neoplasm Recurrence, Local - drug therapy | Male | Neoplasm Recurrence, Local - pathology | Radiotherapy, Adjuvant - adverse effects | Aged, 80 and over | Adult | Female | Hafnium - administration & dosage | Neoplasm, Residual - radiotherapy | Sarcoma - radiotherapy | Oxides - administration & dosage | Hafnium - chemistry | Radiotherapy Dosage | Combined Modality Therapy | Sarcoma - drug therapy | Sarcoma - pathology | Preoperative Care | Neoplasm, Residual - drug therapy | Aged | Nanoparticles - administration & dosage | Slopes | Sarcoma | Toxicity | Tumor cells | Radiation | Feasibility studies | Soft tissue sarcoma | Hafnium oxide | Shrinkage | Radiation therapy | Injection | Tissues | Patients | Nanoparticles | Atrophy | Pain | Magnetic resonance imaging | Experimental design | Safety engineering | Surgery | Hafnium | Adults | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience
by Rutkowski, P and Gronchi, A and Hohenberger, P and Bonvalot, S and Schoffski, P and Bauer, S and Fumagalli, E and Nyckowski, P and Nguyen, B.P and Kerst, J.M and Fiore, M and Bylina, E and Hoiczyk, M and Cats, A and Casali, P.G and Cesne, A. le and Treckmann, J and Stoeckle, E and Wilt, J.H.W. de and Sleijfer, S and Tielen, R and Graaf, W.T. van der and Verhoef, C and Coevorden, F. van
Annals of Surgical Oncology, ISSN 1068-9265, 2013, Volume 20, Issue 9, pp. 2937 - 2943
BACKGROUND: Preoperative imatinib therapy of locally advanced GIST may facilitate resection and decrease morbidity of the procedure. METHODS: We have pooled... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | MESYLATE | SURGERY | PHASE-II TRIAL | THERAPY | MANAGEMENT | ONCOLOGY | KIT MUTATIONS | HIGH-RISK | RANDOMIZED-TRIAL | DOSE IMATINIB | SURGICAL-TREATMENT | Prognosis | Follow-Up Studies | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Benzamides - therapeutic use | Gastrointestinal Stromal Tumors - pathology | Aged, 80 and over | Adult | Female | Neoadjuvant Therapy | Gastrointestinal Stromal Tumors - mortality | Databases, Factual | Survival Rate | Piperazines - therapeutic use | Imatinib Mesylate | Disease Progression | Gastrointestinal Stromal Tumors - drug therapy | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Aged | Neoplasm Staging | Antimitotic agents | Development and progression | Sarcoma | Antineoplastic agents | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: The METASARC observational study
by Savina, Marion and Le Cesne, Axel and Blay, Jean-Yves and Ray-Coquard, Isabelle and Mir, Olivier and Toulmonde, Maud and Cousin, Sophie and Terrier, Philippe and Ranchere-Vince, Dominique and Meeus, Pierre and Stoeckle, Eberhard and Honoré, Charles and Sargos, Paul and Sunyach, Marie-Pierre and Le Péchoux, Cécile and Giraud, Antoine and Bellera, Carine and Le Loarer, François and Italiano, Antoine
BMC Medicine, ISSN 1741-7015, 04/2017, Volume 15, Issue 1, pp. 78 - 11
Background: Well-designed observational studies of individuals with rare tumors are needed to improve patient care, clinical investigations, and the education... 
Chemotherapy | Sarcoma | Outcome | Surgery | Patterns of care | Metastases | 1ST-LINE TREATMENT | PROGNOSTIC-FACTORS | GEMCITABINE | BREAST-CANCER | DOXORUBICIN PLUS IFOSFAMIDE | WEEKLY PACLITAXEL | MEDICINE, GENERAL & INTERNAL | MALIGNANT FIBROUS HISTIOCYTOMAS | RANDOMIZED PHASE-II | EUROPEAN-ORGANIZATION | Doxorubicin - therapeutic use | Practice Patterns, Physicians' - standards | Soft Tissue Neoplasms - mortality | Leiomyosarcoma - pathology | Humans | Middle Aged | Male | Treatment Outcome | Sarcoma - pathology | Sarcoma - therapy | Leiomyosarcoma - therapy | Practice Patterns, Physicians' - statistics & numerical data | Neoplasm Metastasis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sarcoma - mortality | Soft Tissue Neoplasms - pathology | Survival Analysis | Aged, 80 and over | Leiomyosarcoma - mortality | Adult | Female | Aged | Soft Tissue Neoplasms - therapy | Heart | Brain | CD8 antigen | Liver | Metastasis | Cancer therapies | Data bases | Dacarbazine | Failure analysis | Classification | Bone marrow | Diagnosis | Deoxyribonucleic acid--DNA | Cadmium | Evaluation | Cut-off | Mortality | Regression analysis | Population statistics | Patients | Survival | Cyclophosphamide | Adults | Skin | Toxicity | Identification methods | Colorectal carcinoma | Medical services | Clinical trials | Population studies | Bone tumors | Congestive heart failure | Tissue | Databases | Quality | Mathematical models | Age | Correlation coefficient | Statistical analysis | Receiving | Feasibility studies | Breast cancer | Histology | Management | Statistics | Computer programs | Bone cancer | Lungs | Medical prognosis | Breast | Three dimensional models | Elderly | Prostate cancer | Tumors | Peritoneum | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Multi-center evaluation of post-operative morbidity and mortality after optimal cytoreductive surgery for advanced ovarian cancer
by Rafii, Arash and Stoeckle, Eberhard and Jean-Laurent, Mehdi and Ferron, Gwenael and Morice, Philippe and Houvenaeghel, Gilles and Lecuru, Fabrice and Leblanc, Eric and Querleu, Denis
PLoS ONE, ISSN 1932-6203, 07/2012, Volume 7, Issue 7, p. e39415
Purpose: While optimal cytoreduction is the standard of care for advanced ovarian cancer, the related post-operative morbidity has not been clearly documented... 
TRIALS | PROGNOSTIC-FACTOR | RISK-FACTORS | MANAGEMENT | NEOADJUVANT CHEMOTHERAPY | MULTIDISCIPLINARY SCIENCES | RECTOSIGMOID RESECTION | COMPLICATIONS | CARCINOMA | Humans | Middle Aged | Ovarian Neoplasms - pathology | Postoperative Complications - epidemiology | Postoperative Complications - mortality | Young Adult | Aged, 80 and over | Adult | Female | Aged | Referral and Consultation | Retrospective Studies | Neoplasm Staging | Ovarian Neoplasms - surgery | Mortality | Analysis | Patient outcomes | Morbidity | Ovarian cancer | Evaluation | Diaphragms | Statistical analysis | Ovarian carcinoma | Complications | Gynecology | Statistical tests | Patients | Obstetrics | Abdomen | Meta-analysis | Studies | Demographics | Chemotherapy | Womens health | Intestine | Quality | Surgery | Medical prognosis | Cancer | Peritoneum
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Watch and Wait Approach for Re-excision After Unplanned Yet Macroscopically Complete Excision of Extremity and Superficial Truncal Soft Tissue Sarcoma is Safe and Does Not Affect Metastatic Risk or Amputation Rate
by Decanter, Gauthier and Stoeckle, Eberhard and Honore, Charles and Meeus, Pierre and Mattei, Jean Camille and Dubray-Longeras, Pascale and Ferron, Gwenael and Carrere, Sébastien and Causeret, Sylvain and Guilloit, Jean-Marc and Fau, Magali and Rosset, Philippe and Machiavello, Jean-Christophe and Delhorme, Jean Baptiste and Regenet, Nicolas and Gouin, François and Blay, Jean-Yves and Coindre, Jean-Michel and Penel, Nicolas and Bonvalot, Sylvie
Annals of Surgical Oncology, ISSN 1068-9265, 10/2019, Volume 26, Issue 11, pp. 3526 - 3534
The benefits of systematic re-excision (RE) after initial unplanned excision (UE) of soft tissue sarcoma (STS) are unknown. The aim of this study was to... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | IMPACT | MANAGEMENT | LOCAL RECURRENCE | SURGICAL MARGINS | ONCOLOGY | RESECTION | RESIDUAL DISEASE | PROGNOSTIC-SIGNIFICANCE | CHEMOTHERAPY | RADIATION-THERAPY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Distal extremities soft tissue sarcomas: Are they so different from other limb localizations?
by Mattei, Jean‐Camille and Brouste, Véronique and Terrier, Philippe and Bonvalot, Sylvie and Lecesne, Axel and Stoeckle, Eberhard and Italiano, Antoine and Ranchere‐Vince, Dominique and Meeus, Pierre and Laé, Marick and Rosset, Philippe and Rochwerger, Alexandre and Coindre, Jean Michel and Salas, Sébastien
Journal of Surgical Oncology, ISSN 0022-4790, 03/2019, Volume 119, Issue 4, pp. 479 - 488
Background and Objectives Soft tissue sarcoma localization in distal extremities (DESTS) of the limbs (hand/fingers, and foot/toes) is unusual. The literature... 
limb | distal extremity | prognosis factors | soft tissue sarcoma | outcomes | SURGERY | SPARING SURGERY | MANAGEMENT | PROGNOSTIC-FACTORS | RESECTION | RECONSTRUCTION | ONCOLOGY | RECURRENCE | Epidemiology | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors
by Croce, Sabrina and Ducoulombier, Agnès and Ribeiro, Agnès and Lesluyes, Tom and Noel, Jean-Christophe and Amant, Frédéric and Guillou, Louis and Stoeckle, Eberhard and Devouassoux-Shisheboran, Mojgan and Penel, Nicolas and Floquet, Anne and Arnould, Laurent and Guyon, Frédéric and Mishellany, Florence and Chakiba, Camille and Cuppens, Tine and Zikan, Michal and Leroux, Agnès and Frouin, Eric and Farre, Isabelle and Genestie, Catherine and Valo, Isabelle and MacGrogan, Gaëtan and Chibon, Frédéric
Modern pathology, ISSN 0893-3952, 2018, Volume 31, Issue 5, pp. 816 - 828
The diagnosis of a uterine smooth muscle lesion is, in the majority of cases, straightforward. However, in a small number of cases, the morphological criteria... 
SURVIVAL | IMPACT | PROGNOSTIC-FACTORS | LEIOMYOSARCOMA | SARCOMAS | UTERUS | LEIOMYOMAS | STAGE-I | DIFFERENTIATION | PATHOLOGY | PROGRESSION | Chromosomes, Human, Pair 13 - genetics | Smooth Muscle Tumor - diagnosis | Prognosis | Oligonucleotide Array Sequence Analysis | Uterine Neoplasms - pathology | Humans | Middle Aged | Leiomyoma - diagnosis | Gene Expression Profiling | Chromosomes, Human, Pair 17 - genetics | Leiomyoma - pathology | Smooth Muscle Tumor - genetics | Aged, 80 and over | Leiomyosarcoma - genetics | Adult | Female | Uterine Neoplasms - diagnosis | Chromosomes, Human, Pair 5 - genetics | Uterine Neoplasms - genetics | Leiomyosarcoma - pathology | Neoplasm Recurrence, Local | Smooth Muscle Tumor - pathology | Survival Analysis | Aged | Leiomyosarcoma - diagnosis | Leiomyoma - genetics | Chemotherapy | Uterus | Benign | Clinical trials | Hybridization analysis | Smooth muscle | Genomes | Diagnosis | Survival | Tumors | Life Sciences | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Progress in Survival Outcomes in Patients with Advanced Ovarian Cancer Treated by Neo-Adjuvant Platinum/Taxane-Based Chemotherapy and Late Interval Debulking Surgery
by Stoeckle, Eberhard and Stoeckle, Eberhard and Bourdarias, Lionnel and Bourdarias, Lionnel and Guyon, Frédéric and Guyon, Frédéric and Croce, Sabrina and Croce, Sabrina and Brouste, Véronique and Brouste, Véronique and Thomas, Laurence and Thomas, Laurence and Floquet, Anne and Floquet, Anne
Annals of Surgical Oncology, ISSN 1068-9265, 2/2014, Volume 21, Issue 2, pp. 629 - 636
Steady progress in outcomes has been observed after standard treatment by surgery and chemotherapy in patients with advanced ovarian cancer (AOC), but little... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | CYTOREDUCTIVE SURGERY | MANAGEMENT | ONCOLOGY | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Gynecologic Surgical Procedures | Ovarian Neoplasms - mortality | Neoplasm Grading | Cystadenocarcinoma, Serous - therapy | Aged, 80 and over | Adult | Female | Neoadjuvant Therapy | Retrospective Studies | Paclitaxel - administration & dosage | Cystadenocarcinoma, Serous - secondary | Carboplatin - administration & dosage | Survival Rate | Combined Modality Therapy | Lymphatic Metastasis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cystadenocarcinoma, Serous - mortality | Ovarian Neoplasms - therapy | Aged | Neoplasm Staging | Cancer patients | Care and treatment | Analysis | Patient outcomes | Adjuvant treatment | Information management | Ovarian cancer | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Are early relapses in advanced-stage ovarian cancer doomed to a poor prognosis?
by Vidal, Fabien and Guerby, Paul and Luyckx, Mathieu and Haddad, Pascale and Stoeckle, Eberhard and Morice, Philippe and Leblanc, Eric and Lecuru, Fabrice and Daraï, Emile and Classe, Jean Marc and Pomel, Christophe and Filleron, Thomas and Ferron, Gwenael and Querleu, Denis and Rafii, Arash
PLoS ONE, ISSN 1932-6203, 01/2016, Volume 11, Issue 1, p. e0147787
Objective Early recurrence (ER) after completion of therapeutic regimen in advanced-stage ovarian cancer is a challenging clinical situation. Patients are... 
IV OVARIAN | 1ST-LINE TREATMENT | DES CANCERS | CARBOPLATIN | CYTOREDUCTIVE SURGERY | INTERGROUP TRIAL | MULTIDISCIPLINARY SCIENCES | CARCINOMA | EPITHELIAL OVARIAN | CHEMOTHERAPY | PACLITAXEL | Neoplasms, Cystic, Mucinous, and Serous - pathology | Prognosis | Humans | Middle Aged | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Ovarian Neoplasms - pathology | Proportional Hazards Models | Treatment Outcome | Ovarian Neoplasms - mortality | Disease-Free Survival | Ovarian Neoplasms - therapy | Female | Aged | Neoplasms, Cystic, Mucinous, and Serous - mortality | Care and treatment | Relapse | Research | Risk factors | Ovarian cancer | Cancer | Pediatrics | Ovarian carcinoma | Laboratories | Oncology | Metastasis | Multivariate analysis | Cancer therapies | Subgroups | Early experience | Education | Surgery | Statistical analysis | Cytokines | Laparoscopy | Breast cancer | Regression analysis | Survival | Patients | Abdomen | Chemotherapy | Hospitals | Medical prognosis | Stem cells
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Uterine smooth muscle tumor analysis by comparative genomic hybridization: A useful diagnostic tool in challenging lesions
by Croce, Sabrina and Ribeiro, Agnes and Brulard, Celine and Noel, Jean-Christophe and Amant, Frederic and Stoeckle, Eberhard and Devouassoux-Shisheborah, Mojgan and Floquet, Anne and Arnould, Laurent and Guyon, Frederic and Mishellany, Florence and Garbay, Delphine and Cuppens, Tine and Zikan, Michal and Leroux, Agnès and Frouin, Eric and Duvillard, Pierre and Terrier, Philippe and Farre, Isabelle and Valo, Isabelle and MacGrogan, Gaetan M and Chibon, Frederic
Modern Pathology, ISSN 0893-3952, 07/2015, Volume 28, Issue 7, pp. 1001 - 1010
The diagnosis and management of uterine smooth muscle tumors with uncertain malignant potential (STUMP) is often challenging, and genomic data on these lesions... 
LEIOMYOSARCOMAS | CELL NECROSIS | ARRAY | VARIANTS | GENE | SARCOMAS | UTERUS | LEIOMYOMAS | PATHOLOGY | EXPRESSION | P53 | Uterine Neoplasms - genetics | Smooth Muscle Tumor - diagnosis | Uterine Neoplasms - pathology | Humans | Middle Aged | Leiomyoma - diagnosis | Smooth Muscle Tumor - pathology | Leiomyoma - pathology | Neoplasm Recurrence, Local - pathology | Young Adult | Smooth Muscle Tumor - genetics | Comparative Genomic Hybridization | Aged, 80 and over | Adult | Female | Neoplasm Recurrence, Local - genetics | Aged | Uterine Neoplasms - diagnosis | Leiomyoma - genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights